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Calcium oxalate monohydrate is the main inorganic constituent of kidney stones. 
Thus, the study of calcium oxalate (CaOx) crystal formation is of major importance 
for human health. Urinary proteins are believed to have the potential to influence the 
crystallization of CaOx. Some papers have reported that the protein, albumin, 
promotes the nucleation of CaOx crystal by templating effect. However, others 
reported that this protein inhibited the formation of CaOx crystal. Therefore, how 
does the albumin affect the crystallization of urinary stone is still unclear. 
Although some aspects of nucleation and aggregation of CaOx crystals in vitro have 
been studied including the effect of some human proteins, no detailed studies on the 
crystallization of CaOx crystals have been reported to elucidate the effect of these 
proteins. Evidently, an unambiguous understanding of the effects of these proteins on 
the formation of CaOx should be developed. 
Recently, the structural synergy between biominerals and biosubstrates was 
examined. Particular emphasis was placed on the templating effect of the substrate, as 
well as a newly identified supersaturation-driven interfacial structure mismatch effect 
in the context of a new nucleation model. Based on this model, some exciting results 
have been achieved in studying ice, calcium carbonate and hydroxyapatite, through a 
comparative analysis of the effects of various selected additives (salts, and 
biopolymers). To obtain a better understanding on the CaOx crystallization and the 
role of the albumin in the urine, in this work, we employ the mentioned nucleation 
model, to examine the nucleation of Calcium Oxalate Monohydrate and the impact of 
 V
bovine serum albumin (BSA). In addition, we also examine how the BSA influences 
the assembly of CaOx from the kinetics point of view. 
In this study, the influence of the BSA on the nucleation kinetics is discussed. First, 
the presence of BSA lowers the nucleation energy barrier. Second, during the 
nucleation process, the BSA adheres to the kink sites and/or the embryo surfaces; 
thus, the BSA increases the kink energy barrier, and slows down the crystallization. In 
essence, the BSA prolongs the CaOx nucleation process. This is accompanied by the 
increase in nucleation induction time. From the nucleation kinetics study, we also 
deduce that the protein can enlarge the supersaturation range to achieve a better 
crystal assembly. In addition, this conclusion has been confirmed by the crystal 
morphology study.  
Since the BSA favors the formation of Calcium Oxalate Dihydrate (COD) crystal, we 
also discuss the possible role of the albumin in treating the kidney stone. As COD is 
less likely to adhere to the urinary cells and tubes, and it is less harmful to the kidney. 
Moreover, the induction time increase makes the crystals more easily propelled out by 
urine. These factors lead to the conclusion that the albumin plays a positive effect on 
preventing the kidney stone disease.   
Though some progress has been made in our study on the kidney stone and the role of 
protein, this study has also put forward many questions, which still need satisfactory 
answers. I hope that these results would promote further study of the role of albumin 
on the CaOx crystal crystallization leading to an effective approach to control the 
formation of CaOx crystals, and contribute to the treatment of kidney stones. 
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1.1 General Introduction of Biomineralization 
The controlled formation of inorganic minerals in organisms results in the 
biomineralization of crystalline and amorphous materials
1-8
. Mineralization processes, 
which are under strict biological control, are aimed at specific biological functions 
such as structural support
6, 9
 (bones and shells), mechanical strength
7, 10, 11
 (teeth), iron 
storage (ferritin) and magnetic
5
 and gravity reception
12-14
 etc. Studies of chemical and 
biochemical process of biomineralization not only lead to new insights in 
bioinorganic chemistry, but also provide novel concepts in crystal engineering and 
materials science. 
The subject of biominerals covers a wide range of inorganic salts, which serve a 
variety of functions in biology. The field of biomineralization
1-3, 12, 15-17
 covers all 
phenomena that involve mineral formation by organisms. This includes the string of 
50-nm-long magnetite
5
 crystals formed intracellularly by some bacteria, the two 
crystal specula skeleton of the larvae of sea urchins
18
, and the huge molars and bones 
of elephants
19
. We learn that biominerals are “smart” in that they are designed in 
response to external signals
5
. Their functions are almost as varied
2, 3, 5, 16, 17
: sound 
reception, gravity perception, toxic waste disposal, orientation in the earth’s magnetic 
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field, temporary storage of ions, and a diverse array of materials that are stiffened and 
hardened by the presence of mineral. There are many examples
2, 3, 16, 17
 of the control 
of form and microstructure for a mechanical duty. The antler bone of the deer is used 
in fighting and hence has high work of fracture for impact strength. The femur of a 
large animal such as a cow needs to support weight and is stiff with adequate 
toughness. In fact, there are also a great many other examples. 
The body of biomineralization is huge as it covers a large scale of academic field for 
investigation
4, 8, 20-25
. The materials used include more than 60 different mineral types, 
an array of structural proteins and polysaccharides, and many dedicated 
glycoproteins, whose major functions are to control in one way or another the 
mineralization process. The most basic processes in biomineralization operate at the 
nanometer length scales and involve proteins and/or other macromolecules directly in 




Many questions remain to be answered: How can such elaborate inorganic forms be 
sculptured by soft biological structures and systems? In addition, what role does 
structural biology play in the evolution of inorganic morphogenesis? One teasing 
question is whether any of the mineralization mechanisms operating in these 
invertebrates are precursors or even analogs to the large-scale structures of vertebrate 
mineralization, which not surprisingly are the most actively investigated of all 
biominerals. 
The important applications of biomineralization and the need for increased activity 
among structural biologists in this field have attracted much of attention. Clearly, 
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biomineralized tissues such as bones and teeth continue to be of fundamental 
importance in medicine and health care. There are also other important implications 
of biomineralization research for new advances in materials science. For example, 
there is a growing interest in the use of biomineralization proteins and their synthetic 
analogues for the control of crystal properties and organization. These may lead to a 
rethinking of the formation and value of minerals, especially composites in industry. 
It is very likely that biomolecules will be used as templates for the fabrication of 
inorganic systems such as electronic devices, new catalysts, sensors, and porous 
materials, as well as biomimetic structures for more conventional uses in biomaterials. 
In each case, knowledge of the underlying biological structures is the basis for all 
novel applications.  
 
1.2 General Introduction of Calcium Oxalate Crystal 
Calcium oxalate
24, 27-37
(CaOx) is quite common in nature and is found in almost all 
types of living beings, micro-organism, fungi, plants and animals including humans. 
In plants
27
 where a majority of the families of seed plants contain CaOx crystal 
deposits, it plays diverse roles such as storing excess calcium, forming exoskeleton or 
making plants less palatable to foraging animals. CaOx crystal can be found in all 
major groups of photosynthetic organisms
24, 27, 28
 including algae, lower vascular 
plants, gymnosperms, and angiosperms. CaOx crystal is also found in animals but in 
contrast to plants it is most commonly associated with the pathological condition of 
renal stone disease, although it occurs as a structural element in a few animals and as 
a potential defense in others
28, 38
.  
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In man and other mammals, oxalate is endogenously produced as well as obtained 
from the food. Since it cannot be metabolized, oxalate is excreted in the urine
35, 39-41
. 
Urinary over excretion of oxalate may result in crystal deposition in the kidneys, 
formation of kidney stones and eventually in renal failure
42
. A number of people 
suffer from problems due to urinary stones (calculi). Areas of high incidence of 
urinary calculi include the British Isles, Scandinavian countries, northern Australia, 
Central Europe, northern India, Pakistan and Mediterranean countries. Saurashtra 
region, Gujarat has higher prevalence of urinary stones
29
. According to an estimate, 
every year 600,000 Americans suffer from urinary stones. And, the cost of treating 
human urinary stone disease in the United States alone is estimated to be more 2.4 
billion dollars per year
28
. In India, 12% of the population is expected to have urinary 
stones, out of which 50% may end up with loss of kidneys or renal damage. In 
human
35, 39-41, 43-46
, calcium stones are most common, comprising 75% of all urinary 
calculi. Majority of them are calcium oxalate monohydrate (COM) whewellite or 
calcium oxalate dihydrate (COD) weddelite. In general, the urinary calculi are 
composed mainly of crystalline components.  Thus, CaOx crystal is of major 
biological and economic importance. 
The study of urinary stone and CaOx crystal is a rather complicated process. A 
combination of factors (gene and environment) play a role in defining CaOx crystal 
amount, shape, and size and thus function
24, 27, 28
. Stone formation requires 
supersaturated urine, which depends on urinary pH, ionic strength, solute 
concentration and complexation.  Knowledge of the processes involved in CaOx 
crystal formation is relevant to our basic understanding of organs, and specialized 
defense mechanisms. Studies on CaOx crystal formation and its regulation have also 
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provided insights into the fascinating large fluxes of Ca across multiple 
compartments, and for controlling CaOx crystal precipitation so that crystal growth 
does not cause unwanted damaged to cells. Considering the complexity of crystal 
formation, regulation can occur at a number of steps.  
The major components of CaOx crystals are simple, but the resulting crystals can be 
complex in their morphology. Oxalic acid (C2H2O4 ) is a strong organic acid with 
dissociation constants
27
 of Pk1 = 1.46 and Pk2 = 4.40 . Oxalic acid can complex with 
Ca to form highly insoluble CaOx crystals (solubility product, Ksp , at 25
oC  of 
2.32 109  for the monohydrate27) with a striking range of morphologies. To form a 
CaOx crystal, the agents in the environment can act as heterogeneous nucleates to 
lower the metastable limit and promote crystal formation
10, 47-49
. Various charged 
compounds, including organic acids, peptides, polysaccharides, proteins, and lipids, 
have nucleation promoting or inhibiting properties in vitro. These compounds can 
change the physic-chemical dynamics and can affect the rate of formation, hydration 
state, morphology, and aggregation of crystals. Thus, although the chemistry of CaOx 
crystal precipitation is relatively simple, the addition of organic materials in the 
biological system complicates our understanding of the precipitation process.  
 
1.3 Epidemiology of Calcium Oxalate Urolithiasis in Man 
CaOx crystallization in vitro is usually carried out in the context of investigating 
urolithiasis
29, 33, 34, 39, 50-53
. Applications range from studying fundamental physical 
chemistry in simple solutions to developing clinically meaningful tests using urine. In 
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the United State alone, urolithiasis accounts for approximately 200,000 
hospitalizations per year
29, 50
. The incidence of urolithiasis has been increasing 
steadily in industrialized regions of the world since last century. CaOx crystal is by 
far the most common constituent of upper urinary tract calculi and may be important 
in endemic bladder calculi as well.  
Some of the biologic factors that can influence the epidemiology of urolithiasis have 
been investigated:  
1. The adult males are more likely to have symptomatic stones
54
. In industrialized 
societies the urolithiasis occurs predominantly in mid adulthood with a much lower 
incidence in childhood and in the elderly
55
.  
2. There has been general agreement that blacks have a significantly lower prevalence 
of urolithiasis than whites
56
. And, it is believed that the environmental factors that 
result in this race difference
28, 56
.  
3. Individuals who have a family history of urolithiasis
57, 58
 are more likely to form 
urinary tract stones than non-stone formers. Among stone patients with frequent 
recurrences, the likelihood of a positive family history is even higher
57, 58
.  
4. It is known that diets low in animal protein and phosphorus and high in cereals 
favor the formation of endemic urinary stones, particularly in children
59, 60
. A diet rich 
in fiber may inhibit intestinal calcium absorption but may also facilitate absorption of 
oxalate
61
. Finally, the water intake is also an important factor, for a man with the 
urine volume of less than one liter per day, the risk of nucleation of constituents 
leading to calcium stones rises dramatically
62
.  
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As mentioned above, CaOx crystal formation is a fundamental part of the physiology 
of many species. Through the integration of ultrastructral, physiological, biochemical, 
and genetic approaches, the mechanisms responsible for this remarkable 
biomineralization process is being identified; however many features of crystal 
formation remain to be characterized. Thus, a better understanding of the mechanisms 
operating in CaOx crystal nucleation, growth and crystallization is needed to clearly 
characterize those features working in crystal formation, so as to solve those questions 
mentioned before and improve the urolithiasis treatment. 
 
1.4 Objective of This Thesis 
One of the reasons why Biomineralization is so important is its potential application 
in the medical field.  Although, recently, a lot of work has been done on the urinary 
stone study, and some tremendous progress has been achieved, the influence of the 
proteins on the formation of urinary stone is still unclear. Tremendous work has 
deliberately been performed to contribute towards the purpose, namely, the exact role 
of the urinary protein in the urinary stone nucleation, growth and aggregation. These 
results are somewhat confusing due to the conflicting role of the protein predicted. 
This situation demands more concrete data and reasonable interpretation. Until now, it 
is well known that each protein plays its distinguishable part, but what kind of 
consequence and how the protein contributes to this is the hot debated issue. 
As for the albumin, some papers have reported that it promotes the nucleation of 
CaOx crystal, the major component of urinary stone, by templating effect. However, 
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others reported experiments provided opposite results that albumin inhibits the 
formation of CaOx crystal. These conflicts
15, 35, 37, 44, 51, 63
 may arise from the 
experiment methods, but it will never be so simple to resolve them. How does the 
albumin affect the crystallization of urinary stone is still unknown. 
To answer the questions mentioned above, this study is aimed at the investigation of 
how the protein, Bovine Serum Albumin, influences the nucleation of CaOx crystal, 
and the consequent crystal growth and aggregation. We notice that a newly formed 
nucleation theory that has been widely used on the nucleation of ice, CaCO3 and 
hydroxyapatite has contributed a lot to the crystal study. So, it has been employed 
here on the nucleation study of CaOx crystal. As this work is mainly focused on how 
the proteins influence the crystallization, the templating effect of protein is also 
discussed. This study is also aimed to explain how the proteins lower the nucleation 
energy barrier, increase the kink site energy barrier and their potential role in 
inhibiting the formation of CaOx crystal. Lastly, this study intends to investigate the 
crystal morphology change produced by the presence of bovine serum albumin 
(BSA).  
We wish that these results could promote the study of the role of albumin on the 
CaOx crystal crystallization and urinary stone formation. We also wish that this thesis 
could contribute towards research on the protein effect in the biomineralization world. 
The task is immense, but the future is bright. 
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1.5 Organization of This Thesis 
This thesis is composed of six chapters, which include introduction, literature review, 
experiments, results, discussion and conclusion. The contents of each chapter are 
briefly given below. 
The general knowledge on biomineralization is briefly introduced in the first chapter. 
The role of urinary stone to human health and related studies are also briefly listed. 
The second chapter contains the literature review of the general nucleation knowledge 
and theory, which are used as foundation in this study. In this chapter, a newly 
founded nucleation theory is also introduced and discussed. The recent progress on 
urinary proteins and their influence on urinary stone formation are also presented. 
The third chapter describes the techniques used in this study, which include Dynamic 
Light-Scattering system, X-ray diffraction (XRD), High Performance Particle Sizer 
(HPPS), Scanning Electron Microscope (SEM) and Zetasizer. Finally, the chemicals 
reagents used and some related information are listed. 
At the beginning of the fourth chapter, the XRD experiment, which is used to confirm 
the crystals prepared in this study is discussed. Then the CaOx crystal nucleation 
kinetics with the effect of sodium chloride and the protein, bovine serum albumin, is 
examined. In this part, armed with the newly identified nucleation theory, the 
nucleation kinetics is carefully examined and discussed in detail. How the albumin 
influences the CaOx crystal nucleation process is also carefully discussed. 
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The fifth chapter mainly focuses on the CaOx crystal morphology study. The SEM 
pictures of the crystals are examined and how the protein, BSA, influence the 
morphology of CaOx crystal is discussed.  These results mainly serve to confirm the 
conclusions deduced from the previous chapter. 
Results reported in the preceding chapters are summarized in the last chapter: chapter 
six and the potential advantage of albumin in alleviating the urinary stone disease is 
also clarified. Major conclusions are drawn and recommendations on future work are 







2.1 Nucleation Theory 
2.1.1 Introduction of General Nucleation Theory  
The general nucleation process can be described as that
2, 3, 10, 48, 49, 64, 65
 by which the 
constituent units (molecules or ions) in the solution may, on collision, join into groups 
of two or more particles to form dimers, trimers, tetramers, and so forth. However, 
even when a positive thermodynamic driving force
2, 3, 47, 64-66
, μ , is acting on the 
embryos, they are still unstable, until the embryos can reach a critical radius, rc ,  To 
reach the rc , an energy barrier, the so-called nucleation barrier, needs to be overcome. 
During nucleation process, can the embryos reach the critical radius is the main 
concern
2, 3, 47
. Once the nucleation barrier is overcome, the embryos can grow
2, 3, 67
, 
thus the embryo enters the second step of phase transition: growth. 
If nuclei are formed in perfectly clean solution in the absence of any foreign particles 
or surfaces, the nucleation mechanism is referred as “homogeneous” nucleation
3, 67
, 
also sometimes called spontaneous nucleation. But in practical situation, the presence 
of foreign surfaces (in the form of ions, impurity molecules, dust particles, or other 
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surfaces) generally induces “heterogeneous” rather than homogeneous nucleation. 
The heterogeneous nucleation can occur at lower supersaturation than the 
homogeneous nucleation
67
. Both these nucleation processes are forms of primary 
nucleation, so called to distinguish them from the second main category, secondary 
nucleation. It occurs only because of the prior presence of crystals of the material 
being crystallized. The classification
2, 3, 67
 of nucleation phenomena is shown in Table 
2-1.  
Crystals will not grow out of all supersaturated solutions. To create a new phase, the 
system must overcome a certain energy barrier called Gibbs Free energy, G . The 
occurrence of nucleation barrier is attributed to the following two-conservancy 
effects
2, 3, 12, 47, 67
:  
1. Since the crystalline phase is stable, the occurrence of the new phase from the 
mother phase will lead to the lowering of the (Gibbs) free energy of the system; 
2. Due to the interfacial (or surface) free energy, the increase in the size of the 









Crystal of solute 
Primary 
Secondary 
Table 2-1. Classification of nucleation phenomena 
Heterogeneous 
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consequently causes the increase of the Gibbs free energy of the system. 




                                       G  =  - 4r
3
3 μ  +  4r
2  ,                    (2-1) 
where  is the volume of a molecule inside the crystal; r is the radius of the nucleus; 
μ  is the thermodynamic driving force, and  is the interfacial free energy per unit 
area between nucleus and solution. At first, G  increases with r  until it reaches a 
maximum for a value of r , called the critical radius rc , and then decreases as r  tends 
to infinity. This means that a nucleus will be stable once it has grown up to the critical 
size rc . The particular interest is that G  decreases with supersaturation and 
increases with the interfacial crystal/solution free energy. This means that a high 
supersaturation reduces the energy threshold to create a new phase and favors 
Clusters 
G
Increase of surface area 
and surface free energy 
rrc




3 μ  
 4r2






Fig. 2-1. Schematic illustration of the formation of nucleation barrier. 
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nucleation. The presence of foreign particles reduces the free interfacial energy and 
increases the frequency of nucleation. Thus a lower supersaturation is required to 
nucleate when dealing with heterogeneous than homogeneous nucleation.  
In the process of homogeneous nucleation, the nucleation barrier
2, 3, 67
 is then given 
for a spherical nucleus by  
 Ghom o* =
16 cf32
3[μ]2 , (2-2)  
and the critical size of the nuclei is  
 rc = 2 cf / μ , (2-3) 
 μ = kT ln(1+ ) , (2-4) 
where Ghom o* is the nucleation barrier for homogeneous nucleation; k is the Boltzman 
constant, and T is the absolute temperature.  In Eq. 2-4,   is defined13, 65, 68, 69 as the 
supersaturation of solution, and for CaOx crystal, one has  
ln(1+ ) = ln[a(Ca2+ )a(C2O42 ) / ksp ] ,   (2-5) 
where Ksp  is the solubility product at a given temperature; a(Ca
2+ )  is the activity of 
Ca2+ , and a(C2O4
2 )  is the activity of C2O4
2 . 
2.1.2 The Introduction of a New Nucleation Theory 
Since the association between the substrate and the biominerals is largely determined 
by heterogeneous nucleation
2, 3, 12, 14, 28, 47, 67, 70-72
, some nucleation theories examined 
the impact of the nucleation on the kinetics and the formation of the self-organized 
structure of biomineral aggregates. Here, a newly found nucleation theory is 
introduced. Considering the effect of the substrate on both the nucleation barrier and 
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the transport process, as illustrated in Fig. 2-2, the nucleation induction is given 
according to the model
12, 14, 47, 67, 70-72
 as  
 
J = Rs( )
2








,                          (2-6) 
with      
Ghomo* =
16 cf32
3 kT ln(1+ )[ ] ,                                            (2-7) 
and  
( ) ( )mmf = 1
2
1
" ,                                               (2-8) 
f m( ) =
1
4





 are the radius and the density of the substrates respectively; k is the 
Boltzmann constant; T is the absolute temperature; B is the kinetic constant; *homoG  
is the homogeneous nucleation barrier; cf is the specific interfacial free energy 
between the crystals and the mother phase, and  is the volume of the growth units. 
In Eqs. 2-6 to 2-9, m depends on the interaction and (statistical) interfacial structural 
match between the crystalline phase and the foreign bodies, and is expressed as a 
function of the interfacial free energies between the different phases
12-14, 47, 65, 67, 69-73
 
cfscsfm  /)( =  (-1  m  1).                              (2-10) 
Fig. 2-2. Scheme of the process of nucleation at the surface of a 
foreign surface. 
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Here sf, sc and cf correspond to the interfacial tension between substrate and fluid, 
crystal and substrate, and crystal and fluid, respectively. In the presence of substrates 
the nucleation barrier assumes the form




heter mfGG =    (0  f  1).                             (2-11) 
f m( )  is a factor describing the lowering of the nucleation barrier G* due to the 
occurrence of foreign bodies. If f (m) 0 , then the *heterG  vanishes almost 
completely, this means the growing crystals are well oriented and ordered with 
respect to the structure of the substrate. While in the case of f (m) 1 , the substrate 
exerts almost no influence on the nucleation, and the nucleation is controlled by the 
kinetics of homogeneous nucleation, which results in disordered
13, 14, 47, 67-69, 73-75
 
nuclei. Obviously, this factor plays an important role in the determination of the 
heterogeneous nucleation barrier *heterG . The influence of foreign particles such as 
dust particles, proteins or even existing crystallites etc. on the nucleation barrier, and 
the association between the nucleating phase and the substrate can be fully 
characterized by this factor
13, 14, 68, 69, 73
. 
To study the nucleation kinetics, one of the most common ways is to measure the 
induction time (ts) of nucleation at different supersaturations. By definition
12, 47, 67
, the 
nucleation rate J can be expressed as 
)/(1 VtJ s ,                                                   (2-12) 
where V is the volume of the system. It follows then from Eq. 2-6 that 
ln ts =
 f (m)
ln(1+ )[ ]2  ln V (R
s )2N 0 f "(m) f (m)[ ]
1/2
B{ } ,                       (2-13) 
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where 323 )(3/16 kTcf=  , which will remain constant under a given condition.             
2.1.3 The Impact of Foreign Particles on the Heterogeneous Nucleation                                 
Concerning the effect of a foreign body
13, 14, 65, 68, 69, 73-75
, most theories published so 
far mainly focus on the influence on the nucleation barrier
2, 3, 12, 16, 20, 24
. Actually, the 
occurrence of a foreign body will not only lower the nucleation barrier but also affect 
the transport of growth units to the surface of the crystalline clusters. As shown in 
Fig. 2-3, in the case of homogeneous nucleation, the growth units can be incorporated 
into the nucleus from all directions. However, nucleation on a foreign particle will 
cause a reduction in the “effective surface” of the nucleus, where the growth units are 
incorporated into the nucleus. This tends to slow down the nucleation kinetics, which 
cancels the effect of lowering the nucleation barrier. As a result, this will exert a 
direct impact on the formation of self-organized aggregates mediated by nucleation 
and can be described by the interfacial correlation factor f m( )  and f m( )  in the 
previous discussion. These two contradictory effects play different roles in different 
regimes. At low supersaturations, where the nucleation barrier is very high, 
heterogeneous nucleation with an optimal structural match between the crystalline 
Fig. 2-3. Schematic illustration of the effect of foreign particle on the 
transport of structural units from the bulk to the nucleating sites. In 
comparison with homogeneous nucleation (A), the presence of the 
substrate blocks the collision of growth units onto the surface of the 
nucleus. 
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phase and the substrate will be kinetically favored. In this case, the nucleation of 
crystalline materials will be best templated by substrates. However, at higher 
supersaturations, where the nucleation barrier becomes less important, instead of the 
nucleation barrier, it is the effective collisions, described by the factors f m( )  
and f m( ) , that dominate in controlling the kinetics. Thus, nucleation on substrates 
with larger f m( )  and f m( )  will be favored, and lead to a mismatch structure. As 
mentioned above, the templating of a substrate and the supersaturation-driven 
interfacial structure mismatch are two effects playing opposing roles in nucleation. 
Fabricating and engineering the complex structures of functional materials on the 
micro/nano scale can be achieved by carefully adjusting these two effects. 
From Eq. 2-10, we know that m is directly associated with cs, which depends on the 
interaction and structural match between the nucleating phase and the substrate. For a 
given crystalline phase and a substrate, the optimal structural match at 
crystallographic orientation
65, 75
 corresponds to the strongest average interaction or the 
lowest interfacial energy difference. In general, the interfacial structure match 
between the crystalline phase and the substrate changes from a completely correlated 
and ordered state to a completely uncorrelated and disordered mismatch state as m 
varies from 1 to -1. For instance, an excellent structural match m1 implies that 
*
heterG  vanishes almost completely. This occurs only when the growing crystals are 
well oriented and ordered with respect to the structure of the substrate. While in the 
case of m-1, the substrate exerts almost no influence on the nucleation, and the 
nucleation is controlled by the kinetics of homogeneous nucleation, which results in 
disordered nuclei. Due to the anisotropy of the crystalline phase, the available m 
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values should be a discrete set of values. Therefore, the structural match will deviate 
from the optimal structural match position to a secondary optimal structural match 
position. Consequently, m will shift from m=1 to a lower value. Since for the 
crystalline phase, m  and f m( )  take on only those values corresponding to some 
crystallographically preferred orientations, we expect to obtain a set of intersecting 
straight lines from the lnts versus 1/[ln(1+)]2 plot65, 74, 75. These lines with different 
slopes  f m( )  in different regimes indicate that nucleation is governed by a sequence 
of progressive heterogeneous processes. With increasing supersaturation, the 
interfacial correlation factor, f (m) , subsequently increases, as k is constant for a 
given nucleation system. This unambiguously implies that an increase in 
supersaturation tends to drive the interfacial structure correlation between substrates 
and biominerals from a match state to a mismatch state. 
 
2.2 Urinary Protein with the Calcium Oxalate Stone/Crystals 
In the urine, the macromolecules have a controlling influence on the formation of 
urinary stone
2, 29, 36, 37, 76-79
. Here, based on recent significant advances in the science 
and technology, some urinary proteins are presented with major impact on CaOx 
crystallization. Boyce and Garvey
76
 pioneered the modern study of kidney stone 
protein. It is known that protein occupies much more space in CaOx stone, network 
throughout the entire structure of the stone and plays a key role in determining the 
architecture of calculi. The protein is commonly present as a series of concentric 
layers associated with radial striations that appear ordered, rather than random. While 
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the physical features of stone ultrastructure have been reasonably amenable to direct 
microscopic examination, its chemical composition has proved more difficult to 
explore. Despite the fact that stone matrix has been shown to contain an ever-
increasing list of individual proteins, in most cases it is impossible to say with any 
certainty what kind of role they are playing. We will now present the details about 
several urinary proteins that have been subjected to rigorous study because they have 
shown significant influence on the crystallization of CaOx. 
2.2.1 Tamm-Horsfall Glycoprotein 
Tamm-Horsfall Glycoprotein (THG)
76
 is the most extensively investigated urinary 
protein in urolithiasis research, probably because it is the most abundant protein in 
human urine. THG is a renal protein of all placental invertebrates, localized to the 
luminal aspect of epithelial cells of the distal convoluted tubules and distributed 
throughout the epithelial cells of the thick ascending limb of the loops of Henle. 
Despite its abundance in urine, THG is found only sparingly in stone matrix, and it is 
absent from CaOx crystals that precipitate from urine
40
. Some research indicated that 
THG binds only weakly to CaOx crystals. Since it has been accepted that inhibitors 
act by binding to crystal surfaces, it was expected that THG was a poor inhibitor of 
CaOx crystallization. Unfortunately, the conclusion is not solid, because THG 
exhibits different properties depending upon the experimental conditions, and 
consequently, experimental findings are both confusing and contradictory. The 
protein has been reported to act as an inhibitor
41, 44, 45
 and also a promoter
41, 43, 80
. The 
finding is further complicated by the fact that conflicting findings
81
 were obtained in 
the only studies in which the effect of THG was tested in undiluted urine: Hallson, 
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Rose and Sulaiman found that the THG enhanced the deposition of CaOx crystals 
from urine, which was concentrated by evaporation to high osmolalities. However, 
Ryall et al. and Grover et al. found that
44
 the protein was a potent inhibitor of CaOx 
crystal aggregation, although having no effect on CaOx crystal deposition. An 
explanation
41
 for these opposing findings is that while THG promotes CaOx crystal 
precipitation under conditions of high osmolality, where it also links CaOx crystals 
together to form large, loosely connected agglomerates, it is a very effective inhibitor 
of crystal aggregation at more usual urinary concentration. It is also proved that THG 
inhibits crystal aggregation by steric hindrance, not by binding to the crystal 
surfaces
44
. The disagreement was also found in similar conflict relating to its urinary 
excretion. If indeed THG does play a directive role in stone formation, we might 




It would be fair to say that we have not reaped the bounty of study on THG. We know 
that the protein can act both as a promoter and an inhibitor of CaOx crystal processes 
in experimental crystallization systems, however we still cannot say with certainty 
whether it actually plays a key role in the formation of stones. Further studies are still 
required to elucidate its real contribution to urolithiasis, and its interaction, with its 




 has also been the most widely studied protein reported in the 
stone literature. It was first
46
 described in 1978 and then for a number of years been 
deemed as a inhibitor of CaOx crystal growth. NC has been assumed a prominent 
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position in urolithiasis research, having been regarded as the principal inhibitor of 
CaOx crystallization in urine
83
. It has been reported accounting for approximately 
90% of urine’s total inhibitory effect on CaOx crystallization
42, 83
. 
NC has been reported to occur in urine at concentrations
83, 84
 ranging from 5mg/L to 
16mg/L and to contain
46, 83, 85
 2-3 residues of -carboxyglutamic acid (Gla) in its 
primary structure. The Gla component isolated from the urine of stone inhibit CaOx 
crystallization, however the NC isolated from the urine of stone formers was 
reportedly deficient in this amino acid
86
, and the urine from these individuals had 
reduced inhibitory activity. A lack of Gla in NC isolated from kidney stones was 
suggested as the reason why the stones had formed
86
.  
However, a recent paper by Worcester
87
 et al. reassessed the inhibition effect of NC to 
the CaOx crystallization in urine to be no more than 16%. Moreover, more 
researchers
88, 89
 think that this inhibitor ability is shared with a number of other 
urinary proteins, such as uropontin, urinary prothrombin fragment 1 and uronic-acid-
rich. The study of NC should be more carefully done to avoid the possibility of 
producing confusing discussions. 
2.2.3 Uropontin (Osteopontin) 
Uropontin (UP)
76, 89-91
, which reveals complete identity with the N-termini of 
Osteopontin (OP), has exhibited maximal inhibition of CaOx crystal growth in an 
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Osteopontin is an important protein in bone mineralization, where it is thought to 
anchor osteoblasts to bone
9
. Originally isolated from rat bone matrix as a 44 kDa 
phosphorylated protein, it is rich in serine, aspartic acid and glutamic acid-acidic 
amino acids commonly found in proteins involved in biomineralization
93
. 
UP is abundantly founded in Calcium Oxalate monohydrate (COM)
94
 more than in 
Calcium Oxalate dihydrate (COD). In addition, its quantities in COM is substantially 
greater than that reported for NC
86
. UP is present in normal adult urine at a mean 
concentration of approximately 6 108 molar94. Some researches consider that it 
binds more avidly to the CaOx crystal surface than NC, and may consequently be a 
more potent inhibitor. However its inhibitory effect on CaOx crystallization has not 
been tested in urine
94
. Therefore, now, it is not possible to assess its potential effects 
on CaOx crystallization in vivo. Thus, more significant information must be obtained 
before it will be possible to claim with certainty that the presence of UP in urine is 
related specifically to its ability to inhibit CaOx crystallization, and thereby, stone 
pathogenesis. 
2.2.4 Urinary Prothrombin Fragment 1 
Urinary prothrombin fragment 1 (UPTF1)
76
 was isolated from CaOx crystals freshly 
precipitated from urine. Doyle et al.
40
 reasoned that the study of crystals enabled the 
study of urinary proteins, which was directly involved in the crucial crystals 
nucleation phase of stone formation, and thus eliminate any other macromolecule that 
might be introduced by cellular injury. 
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The presence of UPTF1 in CaOx stones
95
 is a consequence of direct inclusion into the 
crystalline architecture. Analysis of calcium phosphate crystal matrix reveals that 
UPTF1 is a major component, whereas in urate crystals it is only a very minor 
constituent
95
. Limited data also demonstrated that the amount of UPTF1 in the 
kidneys of stone formers is significantly greater than those from healthy subjects
96
. 
This is the finding, which has raised a number of research subjects that future research 
must address. 
Until recently, evidence that UPTF1 inhibits CaOx crystallization was only indirect, 
UPTF1 is the most prominent protein in the organic matrix of CaOx crystals 
precipitated from fresh human urine
94
. This, together with the observation that the 
organic matrix is the most potent macromolecular inhibitor of CaOx crystallization 
induced in human
97
, led to the presumption that this inhibitory activity was 
attributable to UPTF1. This presumption was largely justified by the research
98
 that 
UPTF1 is now known to be potent inhibitor of CaOx crystal aggregation in undiluted 
urine. There seems little doubt that the potent inhibitory effect of UPTF1 on CaOx 
crystallization can be ascribed to the Gla domain of the peptide. Derived from its 
parent prothrombin, this region of the protein’s primary structure contains 10 Gla 
residues. 
The study of UPTF1 is still in its early stages. Certainly, preliminary data would 
indicate that it possesses all the features expected of a significant macromolecular 
urinary inhibitor, including potent activity in undiluted urine. Nonetheless, the true 
role of UPTF1 must remain speculative until a cause and effect relationship between 
the protein and stone pathogenesis can be unequivocally demonstrated. 
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2.2.5 Uronic-Acid-Rich protein 
Uronic-acid-rich (UAP) protein was first described in 1993 by Atmani et al
89
. Now, 
there is relatively little published information about UAP
76
, but it was stated 
undoubtedly very prominent in forthcoming stone literature. The inhibitory activity
99
 
of UAP was determined in an inorganic CaOx crystallization system, where it 
strongly retarded CaOx crystal growth. And, it was also reported
99
 that this activity is 
reduced in stone formers compared with normal controls. The protein has also been 
isolated from rat urine
100
 and shown to possess very similar properties to the human 
urinary protein. 
Despite having been the subject of investigation for some years, the true physiological 
function of UAP remains a mystery. It is possible that its clinical usefulness will also 
extend to the treatment of human kidney stones. Unfortunately, the effect of UAP on 
CaOx crystallization in human urine has not yet been determined
88
. It is clear, that 
there is an urgent need to clarify the role of UAP in stone formation. 
2.2.6 The Questions Remaining 
The study of stone proteins has come a long way in recent years
76
, but the knowledge 
we have gained so far has been offset to a large extent by conflicting findings, some 
of which have simply deepened the mystery of the role of proteins in stone formation. 
New technology has enabled us to identify all the involved proteins, but in every case, 
we cannot say with much certainty just why they are there – whether they are good, 
bad or indifferent. Much of the confusion and contradiction that abound in the 
literature concerning protein macromolecules can be ascribed directly to the habit, of 
drawing conclusions about macromolecules’ effects in stone formation from data 
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derived from aqueous inorganic or simple organic systems. Such systems do not 
reproduce the complex ionic milieu of urine and we cannot expect inhibitors to 
exhibit the same effects in splendid isolation at low ionic strength, as they would in 
the urinary soup. It is to be hoped that in the future, results derived from inorganic 
media will be regarded with an appropriate degree of caution and more information 
will be treated using crystallization systems based on urine. Of course, no 
experimental crystallization system will ever replace the surfaces, the fluid and 
concentration dynamics, the twists and turns of the environment of the human kidney. 
As each new protein is added to the list of urine component, it is becoming 
increasingly apparent that there is no single ingredient that alone will carry the blame 
for the fact that some of us suffer from stones, or take the credit for the fact that the 
majority of us, happily, do not. Every protein is potentially an activity protagonist in 
stone pathogenesis until proven otherwise. Future research intent on identifying those 
macromolecules rightfully entitled to a place as participants in CaOx crystallization 
processes, should ensure that their effects are tested in urine, and not neglect the 
possible contribution of other urinary components, for this approach carries the 
promise of discovering their true role in stone pathogenesis. 
  
CHAPTER THREE 
Experimental Techniques and Materials 
3.1 Applied techniques 
To carry out the study on how the BSA influences the crystallization of CaOx, some 
techniques are utilized. Here, in this part, the following experimental setups are 
introduced: the Dynamic Light Scattering system (DLS), Scanning Electron 
Microscope (SEM), X-ray diffraction (XRD), Zetasizer and High Performance 
Particle Sizer (HPPS).  
3.1.1 Dynamic Light Scattering 
We noted that the Eq. 2-12, )/(1 VtJ s , is potentially useful in studying the nucleation 
kinetics. From this equation, we know that the nucleation rate is inversely 
proportional to the induction time and the volume. Under a given condition, if V  
could be kept constant, we could find the direct correlation between the nucleation 
rate and the induction time. This can be an important step to obtain a set of consistent 
and reproducible data to study the nucleation kinetics. Therefore, it is necessary to 
find a reliable way to measure the induction time. 
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In our study, the Light Scattering system, Brookhaven BI-200SM dynamic Light 
Scattering (DLS) system, was employed to measure the nucleation induction time, as 
shown in Fig. 3-1. This device is armed with a He-Ne laser (632.8nm ) source, thus it 
can detect particles of size down to 2nm , which allows an in situ measurement of the 
nucleation process and of the size increase of the nuclei.  
Fig. 3-2. Schematic illustration of the dynamic light scattering setup 
Fig. 3-1. The picture of the Brookhaven BI-200SM Dynamic Light 
Scattering  (DLS) system used in the study.  
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Light Scattering occurs when polarizable particles in a sample are bathed in the 
oscillating electric field of a beam of light. The varying field induces oscillating 
dipoles in the particles and these radiate lights in all directions. The scattered intensity 
is proportional to the number and size of the particles. Light scattering has been 
employed in many areas of science to determine particle size, molecular weight, 
shape, diffusion coefficients etc. The schematic of the principle of the dynamic light 
scattering set up is illustrated in Fig. 3-2. In this study, by mixing the ingredients 
calcium chloride and sodium oxalate (CaCl2 and NaOx) at time t = 0 , the scattered 
light intensity is monitored to follow the nucleation and growth of CaOx crystals. The 
kinetics of nucleation can be examined because of the correlation between the 
nucleation induction time and supersaturation
101
. During the crystallization process, 
what we normally measure is tmeasure , which is defined as the mean time elapsing 
before appearance of an observable amount of the new phase (normally, this new 
phase is crystal). Actually, tmeasure = tgrow + tnucl  ( tgrow the time for the growth of crystals 
to be observed, nuclt  is the induction time for nucleation). While, tnucl = tnonst + ts  ( nonstt  
is the transient period, it is the certain time required to establish nucleation from time 
zero to the steady state, and it is associated with nucleation of the nonstationary state; 
st  is the real induction time). It follows then that tmeasure = tgrow + tnonst + ts . In this 
system, the laser light scattering method promises the detection of particles from 
several nanometer to several tens of nanometer, so the crystals with a sufficiently 
small size can be detected, then, we can have tgrow << tnucl (= tnonst + ts ) . We can even 
assume tgrow  0 . In addition, nonstt  is determined largely by the diffusivity of 
nucleation species. If the mother phase is not too viscous, the nonstt  equal to a few 
microseconds. This implies that snonst tt << . In conclusion, we can approximate that 
                                                                CHAPTER THREE      Experimental Techniques and Materials 
 30 
tmeasure  tnucl  ts . In other words, this implies that under normal condition, the 
nucleation rate J is time-independent. 
The DLS is controlled by a computer. The software screen is shown as Fig. 3-3. The 
left-up window is the control panel, which provides orders to run the DLS system, 
and from which some relative parameters can be set, changed and displayed. The 
right-down panel displays the result. From this display window, we can read out the 
induction time. 
3.1.2 Scanning Electron Microscope  
The Scanning Electron Microscope (SEM) is extremely important in finding new 
applications in nanotechnology. With the advance of nano-fabrication techniques, the 
SEM technology has been developed to study the structures and topography in the 
Fig.3-3. The controlling software of the Dynamic Light-
Scattering system.  
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micro scale.  
The SEM is a microscope that uses electrons rather than light to form an image, thus 
there are many advantages to use the SEM instead of a light microscope. The SEM 
has a large depth of field, which allows a large amount of the sample to be in focus at 
one time. The SEM can produce images of high resolution, which means that closely 
spaced features can be examined at a high magnification. As most SEMs only require 
the sample to be conductive, preparation of the samples is relatively easy. The 
combination of above mentioned merits make the SEM one of the most heavily used 
instruments in nano research areas today. 
The SEM working principles is that: in vacuum situation, the scanning electron 
microscope generates an electrons beam. After being collimated by electromagnetic 
condenser lenses, and focused by an objective lens, the electrons beam scans across 
the surface of the sample by electromagnetic deflection coils. The primary imaging 
method is the collecting of secondary electrons that are released by the sample. The 
secondary electrons are detected by a scintillation material that produces flashes of 
light from the electrons. There is a photomultiplier tube used to detect and amplify the 
light flashes, whose illumination and shadowing show a quite natural looking surface 
topography. The resolutions of SEM are currently limited to around 25 Angstroms.  
In this study, we used the JSM-6700F, which is a field emission scanning electron 
microscope (FESEM) incorporating a cold cathode field emission (FE) gun, ultra high 
vacuum, and sophisticated digital technologies for high resolution and high quality 
imaging of microstructures. Featuring a conical FE gun and a advanced objective 
lens, the system is capable of high resolution imaging as well as high quality real time 
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image display at all scan speeds, and capable of observation and recording of superior 
images. 
The accessories include an auto fine coater (JEOL, JFC-1600). This coater, which 
consists of a main unit and a pump, is designed mainly to prepare specimens for SEM 
observation. As it is easy to set the chamber pressure and the sputtering current, the 
coater can coat biological and other nonconductive specimens with  a thin layer of 
platinum to increase conductivity efficiently. 
3.1.3 X-ray diffraction 
X-ray diffraction (XRD) is the most important method for identifying the variety of 
crystalline mineral species. X-ray diffraction has been used in two main areas, for the 
“fingerprint” characterization of crystalline materials and the determination of their 
structure. The basic principle is that each crystalline solid has its unique characteristic 
X-ray powder pattern, which may be used as a "fingerprint" for its identification. X-
ray diffraction is one of the most important characterization tools used in solid state 
chemistry and materials science. It is usually used in combination with a database of 
Fig. 3-4. Illustration of the Bragg’s law, the reflection of x-rays 
from two planes of atoms in a solid. 
d  
Incident rays                                                                Reflected rays 
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known crystalline structures. The XRD method is non-destructive and requires only 
small amounts of material.  
As illustrated in Fig. 3-4, the geometry generally used is the conventional -2 (or 
Bragg Brentano) geometry in which the angle of the diffracted beam equals the angle 
of incidence with respect to the sample surface. X-ray reflection takes place from 
lattice planes according to Bragg's Law:n = 2d sin . Where d is the lattice spacing; 
 is the wavelength of the X-rays;  is the glancing angle of reflection, and n is the 
order of the reflection, which can be any whole number.  
In this study, we employed the Philips PW 1729 (Eindhoven, Netherlands) X-ray Its 
radiation is emitted by copper, whose characteristic wavelength for the K radiation is 
=1.5418Å. After the incident beam strikes a powder sample, the diffracted beam is 
detected by a moveable detector, which is connected to a chart recorder. In normal 
use, the counter is set to scan over a range of 2  values at a constant angular velocity. 
Routinely, a 2  range of 5 to 70 degrees is sufficient to cover the most useful part of 
the powder pattern, and scanning may cost about 30 minutes to obtain the trace. 
3.1.4 Zetasizer  
Almost all particulate or macroscopic materials in contact with a liquid can acquire 
electronic charge on their surfaces. A charged particle will attract ions of the opposite 
charge in the dispersant, forming a strongly bound layer close to its surface. Those 
ions further away from the core particle make up a diffuse layer, more loosely bound 
to the particle. Within this diffuse layer is a notional boundary, inside which the 
particle and its associated ions act as a single entity, diffusing through the dispersion 
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together. The plane of this boundary is known as the surface of hydrodynamic shear, 
or the slipping plane. The potential at this boundary is known as the zeta potential. Its 
magnitude is affected by both the nature of the particle surface, and the composition 
of the dispersant. 
The zeta potential is an important parameter, which is related to the electrostatic 
repulsion between colloidal particles and thereby to the stability of the particles 
against aggregation. In addition, the zeta potential is a direct measure of the adsorption 
of charged molecules or ions on the surface of the particles, and a measure of the 
magnitude of the repulsion or attraction between particles. Its measurement brings 
detailed insight into the dispersion mechanism and is the key in electrostatic 
dispersion control. By measuring a concentration series, the point of zero charge can 
be determined. 
The electrophoresis instrument utilized in the study is the Zetasizer 2000 of Malvern 
Instruments. It can measure the electrophoretic mobility of colloidal particles in an 
ionic solution and then calculates the zeta potential within certain assumptions.  
3.1.5 High Performance Particle Sizer  
Particle size measurement is an extremely important parameter across most branches 
of industry. A High Performance Particle Sizer (HPPS) is an instrument for measuring 
the size of molecules in solution or the size of particles in dispersion. The basic 
principle behind HPPS is Dynamic Light Scattering (DLS), also known as Photon 
Correlation Spectroscopy (PCS) or Quasi-Elastic Light Scattering (QELS). The DLS 
measures Brownian motion and relates it to the size of the particles. When a group of 
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particles is illuminated by light (usually laser), the light scattered by the particles will 
produce a speckle pattern consisting of areas of light and dark. Particles suspended in 
a liquid constantly move due to Brownian motion and hence the intensity of light in 
the speckle pattern keeps fluctuating. The DLS measures the rate of the intensity 
fluctuation using a digital correlator and uses it to calculate the size of the particles in 
the sample.  
In this study, we employed the Malvern HPPS (High performance particle sizer), 
which can measure particles in the range 0.6nm  to 6μm . This setup can measure 
solution with the concentration ranging from 0.00001 vol% (0.1ppm) to 20 vol% with 
a temperature controlled range of 10  90oC , and only a very small sample of 
between 12μl  to 3ml  is required. Moreover, measurements can be made in 
conventional disposable plastic or glass cuvettes, eliminating the possibility of cross-
contamination. The HPPS has the highest sensitivity of any dynamic light scattering 
(DLS) system available, and it uses a patented optical system called Non-Invasive 
Back-Scatter (NIBS). 
 
3.2 Chemical Reagents  
During this study, three reagent-grade chemicals: Calcium chloride dihydrate 
(CaCl2 2H2O ), Sodium Oxalate (Na2C2O4 ) and Bovine Serum Albumin (BSA) 
were employed. The chemical reagents were weighed by electronic balance  
(Shimadzu, Aw220), with an accuracy of 1mg.  
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Calcium chloride dihydrate (CaCl2 2H2O , molecular weight of 147.02g/mol) was 
bought from Sigma Company with purity of 99%. It is odorless coarse white powder 
or a mixture of coarse white powder with medium sized granules. It is an irritant 
chemical and very toxic if inhaled. CaCl2 2H2O  can freely dissolve in water with 
heat liberation, and forms a colorless solution. If CaCl2 2H2O  is exposed in open 
containers, it will pick up moisture from the air and form granules, and finally go into 
solution. Since the calcium chloride dihydrate is hygroscopic, the measuring process 
was kept as short as possible. The purpose of minimizing the time that the reagent is 
exposed to the air is to reduce the mass changing resulted from the absorbed moisture 
from the air. Once diluted in water at the concentration of 1M, at 25oC , the pH of the 
aqueous solution ranges from 5.0 to 8.0.  
The Sodium Oxalate (Na2C2O4 , molecular weight of 134.01g/mol) was bought from 
Merck Company, with the purity of 99.8%. It is harmful white powder, and contact 
with skin should be avoided. The solubility at 20oC is 3.7g in 100g water, and the pH 
of the aqueous solution is around 7.0. 
In the solution of Na2C2O4 , the C2O4




+ 2H +  HC2O4 + H +  H2C2O4 .                            (3-1) 
Thus, the oxalate ion concentration must be estimated from the analytical value for 
total acid. This is done by calculating the ion fractions for the diprotic acid, oxalic 
acid. Since, [Oxalatic]total = [H2C2O4 ]+ [HC2O4
 ]+ [C2O4
2 ] , the dissociation 
constants
27
 of H2C2O4  are Pk1 = 1.46 and Pk2 = 4.40 . We have 
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[H ]2 + K1[H ]+ K1K2
.                                 (3-2) 
In this study, the pH was adjusted to 6, then [C2O4
2 ] [oxalatic]total equal 97.55% , 
which is extremely important in calculating the ion strength and consequently the 
supersaturation. 
As the calcium chloride can cause irritation, especially to the eye and skin, and the 
sodium oxalate is toxic, to provide protection, goggle, gloves and the lab coat were 
necessary during the experiment. 
The protein, BSA, was purchased from Sigma Company, with the purity of 98%. 
Normally, it should be stored at the temperature of 4 oC  in the refrigerator. It has a 
good binding capacity for water, Ca2+ , Na+ , K + , fatty acids, hormones, bilirubin and 
drugs. As the synthetic product of the liver and the main protein of plasma, albumin
63
 
is a well-characterized protein with a molecular weight of 6.9 104 , a size 
of11.6  2.7  2.7nm  and isoelectric point of  about 6. Its main function is the 
regulation of the colloidal osmotic pressure of blood. Moreover, it will cause an 
allergic reaction in human. 
The reaction equation of CaCl2  and Na2C2O4  can be expressed as:  
           CaCl2 + Na2C2O4 + xH2O = CaC2O4  xH2O + 2NaCl x = 1,2,3        (3-3) 
Here, the CaC2O4  xH2O  denotes all of the three possible products, that is the three 
crystal phases. So, it could be CaC2O4 H2O  (COM, calcium oxalate monohydrate), 
CaC2O4 2H2O  (COD, calcium oxalate dihydrate) and CaC2O4  3H2O  (COT, 
calcium oxalate trihydrate). The products depend on the experimental conditions, 
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under which they are synthesized, such as the ion strength, temperature, the additives 
and so forth.  
 
3.3 General Parameters of BSA 
When the concentration is set to 1mg / ml , at 25oC , the measured size of BSA using 
HPPS is 10.99 ± 0.80nm . In this study, the membrane filter, whose pore size is 
0.2μm , and the filter paper (Grade 1, Whatman) with pore size of 12  25μm  are 
employed to eliminate the effect of inevitable dust particles in the solution. The size 
measurement proved that the protein could freely pass through the filter and the filter 
paper and, in addition, the filtering process had not produced any negative effect on 
the study. 
For a normal person, the pH of urine is around of 6.0. Therefore, the zeta potential of 
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Fig. 3-5. The Zeta Potential of the BSA. This shows that at conditions 
of the present study, the BSA almost has no charge. 
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BSA at the pH is 6 is measured using the Zetasizer. According to the result (Fig. 3-5), 
we find that the zeta potential of BSA is almost zero, which means that in the 
presence study, the BSA is neutral.  As pI is the pH value at which the molecule has 
no net charge, the pI of BSA is 6.0.  
  
CHAPTER FOUR 
CaOx Nucleation Kinetics  
To make clear how the protein, BSA, influences the formation of CaOx crystal from 
the kinetic point, the experiment was carried out in two steps. The first is to study the 
formation of CaOx crystal without the protein (BSA). The second is to examine the 
influence of the protein. By comparing these results, the role played by the protein, 
albumin in the formation of CaOx crystal could be discovered.  
 
4.1 X-ray Diffraction of CaOx Crystal 
At first, the crystal phase must be verified to check whether the presence of BSA has 
changed the crystal phase. Therefore, the initial step is to carry out the X-ray 
Diffraction (XRD) patterns study. 
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4.1.1 Sample Preparation 
To examine the crystal phase by the X-ray Diffraction, the first step is to prepare the 
crystal samples. The bulk solution of CaCl2 and NaOx are prepared by dissolving the 
reagents with the DI water and then sonicating. The concentration of the two chemical 
reagents is fixed at, 0.7mM , 1.0mM , 1.5mM , 2.0mM , 3mM  and 5mM  
separately. After this, the mentioned two kinds of solutions, of the same concentration 
are mixed slowly. During the mixing process, the solution changes from clear to 
opaque, and then small white particles are precipitated slowly. The mixture solution is 
filtered using a filter paper. Then, the filter paper, with the white particles adhered to 
it, is kept in an oven at 30oC  for 20 hours. In this process, the filter paper loses 
moisture and becomes dry. From the dried filter paper, the crystal powder is carefully 
collected and transferred to the XRD device sample holder. After packing, the powder 
holder is loaded into the sample changer. Finally, the x-ray diffraction pattern is 
obtained.  
The next step is to study the effect of BSA on the CaOx crystal phase. The method of 
sample preparation is almost the same as in the pervious step, except that while 
dissolving the CaCl2 and NaOx, the albumin is added at different concentrations 
ranging from 40mg/L to 400mg/L. 
The x-ray diffraction patterns obtained in the above two steps are compared with 
those of CaOx crystals listed by the Joint Committee on Powder Diffraction Standards 
(JCPDS) powder diffraction database. 
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4.1.2 The Influence of BSA on the CaOx Crystal Phase 
The CaOx crystals, especially the Calcium Oxalate Monohydrate (COM) crystal 
structure is well known and thoroughly discussed
18, 102
. According to the JCPDS 
database, calcium oxalate monohydrate
8, 18, 31, 33, 52
 has monoclinic symmetry and 
belongs to the P21 / c  space group with parameters a=6.29, b=14583, c=10.116, 
=109.46. While the Calcium Oxalate Dihydrate (COD)31, 33 has tetragonal symmetry 
and belongs to the I4 / m  space group with parameters a=12.35, c=7.363. The 
Calcium Oxalate Trihydrate (COT)
103
 crystal has triclinic symmetry, with the 
parameters as a = 6.076 , b = 7.174 , c = 8.467 ,  = 76.65 ,  = 70.85 ,  = 70.91 . 
Among them, the COM is thermodynamically more stable than COD, and COD is 
more stable than COT. 
The XRD pattern of CaOx crystals obtained from the solution without BSA is shown 
in Fig. 4-1. By comparing with those of CaOx crystals listed by the Joint committee 
on Powder Diffraction Standards power diffraction data, the result shows that the 
crystal is COM. However, with the presence of BSA, the result is different. The XRD 
pattern of CaOx crystals obtained from the solution in the presence of BSA is shown 
in the Fig. 4-2. This figure shows that the sample crystals are a mixture of COD and 
COM. From the JCPDS data, we know that the crystal faces with open circle indicate 
the presence of COM, and the asterisks indicate the presence of COD crystal. 
Moreover, the intensity indicates that, in the sample, the majority is COM, while only 
a small portion is the COD. These experimental results indicate that the presence of 
BSA favors the formation of COD crystal. 
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Fig. 4-2. XRD pattern of CaOx Crystals obtained from the solution 
with the BSA. The crystal faces with open circle indicate the presence 
of COM crystal. The asterisks indicate the presence of COD crystal. 
Fig. 4-1. The XRD pattern of CaOx crystals obtained from the 
solution without BSA. By comparing with those of calcium oxalate 
crystals listed by the Joint committee on Powder Diffraction 
Standards powder diffraction data, the result confirmed that the 
crystal is COM. 
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4.1.3 The Medical Effect of COD and COM 
The analysis of CaOx crystals in urine shows that the dihydrate form is present in 
healthy subjects and stone formers, whereas the monohydrate, which is 
thermodynamically more stable and constitutes the core of most urinary stones, is 
present in stone formers only. So promotion by albumin of CaOx crystallization with 
specific formation of dihydrate form might be protective
32, 51
. In addition, it is known 
that COM is prevalent in kidney stones
32, 51
, and COD is more commonly excreted in 
urine. Consequently, it has been proposed that preferential formation in vivo of COD, 
rather than COM, protects against stone formation because they are less likely to 
adhere to renal tubular cells. It is also evident that COM crystals are more injurious to 
cell membranes than are COD crystals, and the binding of COM and COD crystals to 
cultured renal cells is with different face-selective affinities. Thus, the COM more 
easily adheres to the well of the kidney and/or renal tubule than COD. Therefore, the 
difference between the mono- and dihydrate forms of calcium oxalate might 
determine whether crystals are expelled harmlessly in the urine or are retained within 
the kidney and induce the formation of calculi. The above mentioned process and 
Fig. 4-3. Scheme showing of a renal tubule, in which 
supersaturated urine with CaOx is flowing. The arrow 
indicates the flow direction of the urine. In the urine, after the 
nucleation and growth of CaOx, most of the COM is bonded 
to the renal tubule, while most of the COD is propelled out. 
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effect is illustrated in the Fig. 4-3. In the urine, after the nucleation and growth of 
CaOx, most of the COM is bonded to the renal tubule, while most of the COD is 
propelled out. 
 
4.2 CaOx Nucleation Kinetics Study 
4.2.1 Sample Preparation 
Sample preparation consists of three parts: glassware cleaning, solution preparation, 
and solution purification. The first and the third steps share the same major feature, to 
alleviate the possibility that dust influences the experiment data. This is because: On 
the one hand, in the light scattering measurements, dust is a major problem. Dust is a 
general name given to any undesirable, large scatter that contributes to the signal. As 
in our experiment, the light scattering system cannot distinguish the dust from the 
newly born crystals. This can produce puzzling data. Most often dusty samples limit 
the reproducibility of the results. Unfortunately, dust can also yield systematic errors. 
Dust is much more of a problem in polar liquids, especially in water. On the other 
hand, the dust can also affect the nucleation process of the CaOx crystal. It will not 
only work as the substrate that will promote the nucleation by lowering the nucleation 
energy barrier, but also work as the additive that could adhere to the nucleation and 
growth kinks sites, thus slow down the nucleation and growth rate. Therefore, the dust 
must be removed as much as possible. 
To remove the dust, the glassware and reagent solutions were treated separately in 
two different ways. For the glassware, all the beakers, glass cells, flask and other 
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glassware were washed carefully first by chromium acid, then by DI water. This 
process was repeated twice, and finally the glassware was cleaned by acetonee. The 
purpose of this whole process was to make sure that all the unwanted dust and organic 
contaminant could be washed away.   
Stock solutions were prepared by dissolving reagent-grade chemicals in deionized 
water and sonicated. Dozens of samples with concentrations ranging from 3.6mM to 
5.2mM of were prepared by gradually diluting the stock solutions. Then, the filter was 
utilized to remove the dust and other impurity particles in the solution. Multiple 
passes were necessary because filters cannot trap all the dust during the first passage.  
Both kinds of solutions (calcium chloride and sodium oxalate), with the same 
concentration, were injected into the cells of light scattering system to examine the 
nucleation kinetics of CaOx formation from the reactants. The induction time ts was 
measured by monitoring the photon count rate recorded by the DLS equipment 
against time. Subsequently, to simulate the body fluid, the salt sodium chloride was 
added at the concentration of 140mM. Separately, the BSA was also added to the 
solutions with the concentration of 0.5mg/L and 1mg/L, to study its effect on the 
CaOx nucleation. 
4.2.2 The Effect of Supersaturation and Ion Activity on Nucleation Kinetics 
 Based on Eq. 2-13, and related discussion, we know that the plot of ln(ts )  versus 
1 [ln(1+ )]2  can be made. Thus, for a given system (, B = constant), we can 
determine the  f (m) , which is the major factor in the study of the nucleation 
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kinetics. Therefore, we can analyze the nucleation kinetics under various effects, such 
as the supersaturation and the substrate.  
To examine the influence of the supersaturation on the nucleation kinetics, for CaOx 
crystal, the first step is to calculate the ion activity and supersaturation. The 
supersaturation of a system may be expressed in a number of different ways, and 
considerable confusion could be caused if the basic units of concentration are not 
clearly defined. The first statistical theory of electrolyte solutions, developed by 
Debye and Hückel
3, 65
 in 1923, enabled the successful interpretation of the behavior of 
ions in dilute solution. 
To utilize the Eq. 2-5, the ion activity should be calculated first. According to Debye 
and Hückel, the effective concentration of an ion in solution (expressed as its 
chemical activity) differs from its actual concentration by a factor dependent on the 
electrical field strength (as defined by the ionic strength) of the solution. In simple 
terms, this correction allows for the nonspecific effects of other ions in the solution on 
the true chemical activity of the ion under consideration. To obtain the activities of 







 .                                                          (4-1) 
Where ci represents the concentration of the i
th
 ion and zi the ion charge. According to 
the Extended Debye-Huckel theory, the activity coefficient  can be calculated by not 
only taking the ion size into account, but also the temperature and the solvent effect, 
while resulting improved accuracy of the prediction. Therefore, the following 
expression of the activity is applicable for solutions having much higher ionic 
strengths, especially for the multi-ionic systems: 













= ,                                                  (4-2) 
where  is the hydrated ionic radius. In conclusion, the activity of the ions can be 
obtained using the equation 
 ca =  .                                                       (4 - 3) 
Based on above discussion, equations and experiment data, the ln(ts )  versus 
1 [ln(1+ )]2 plot for the CaOx homogeneous nucleation was obtained, as presented 
in Fig. 4-4 (A). According to Eq. 2-13, for a given system (, B = constant), we can 
analyze the effect of the supersaturation in terms of the variation of the slope,  f m( ) , 
of these plots. As shown in Fig. 4-4 (A), the curve can principally be fitted by two 
intersecting straight lines with different slopes. As illustrated in Fig. 4-4 (B), with the 
supersaturation increases, f m( )  increases abruptly, at the point where the 
supersaturation equals 780.15. This indicates that the nucleation is controlled by two 
discrete values of f m( )  within the corresponding regions. From Fig. 4-4 (B), we 
know that in region I, where the supersaturation is lower than 780.15, the  f (m)  
equals 1016.5, while in region II, where the supersaturation is higher than 780.15, the 
slope equals 2579.1. These lines with different slopes  f m( )  in different regimes 
indicate that nucleation is governed by a sequence of progressive homogeneous 
processes.  
The ln(ts )  versus 1 [ln(1+ )]2  plot for the CaOx crystal nucleation under the effect 
of NaCl is presented in Fig. 4-5 (A). The curve can also be fitted by two intersecting 
straight lines with different slopes. Since   is constant, as shown in Fig. 
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Fig. 4-4 (B). Plot of 
 
 f (m)    for CaOx homogeneous nucleation. With 
the increase of supersaturation, the interfacial correlation factor f m( )  will 
increase abruptly at a certain supersaturation. 
Fig. 4-4 (A). Schematic plot of lnts~1/[ln(1+)]2 for CaOx 
homogeneous nucleation. Within the range of supersaturations, two 
fitted lines with different slopes intersect each other, dividing the space 
into two regimes.  
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4-5 (B), when the supersaturation increases, f m( ) ' increases abruptly at the point, 
where the supersaturation is 2273.94. The slopes are 8164.7 in region II', where the 
supersaturation is higher than 2273.94, and 1778.6 in region I', where the 
supersaturation is lower than 2273.94. This indicates that the nucleation is also 
controlled by two discrete values of f m( ) ' within the corresponding regions. These 
lines with different slopes  f m( ) ' in different regimes indicate that nucleation is still 
governed by a sequence of progressive homogeneous processes with the addition of 
NaCl, which provides the buffering effect. 
By comparing Figs. 4-4(A) and 4-5(A), we find that with the addition of NaCl, at the 
same induction time, the concentration of CaCl2 and Na2C2O4 increase dramatically. 
This indicates that in the presence of NaCl, the nucleation induction time for CaOx 





 will not change much due to the buffering effect of additive ions, 
which can influence the activity coefficients by changing the ionic strength. This 
implies that the presence of NaCl inhibits the nucleation of CaOx crystal; moreover, 
the accumulation of supersaturation of CaOx crystal for nucleation in a biological 
system could be buffered, due to the high concentration of other ions. It follows that 
the effect of the supersaturation-driven interfacial mismatch can be suppressed to 
some extent by increasing the ion strength. Moreover, in the kidney, the passage time 
of urine through the narrowest part of the urinary tract, the nephron, is approximately 
three minutes. Therefore, the influence of NaCl to increase the induction time may 
allow the crystals formed to remain small enough during that time to be excreted 
freely
28
. These can be parts of the reasons that though the urine is supersaturated with 
CaOx crystal, many of us still do not have the kidney stone. 
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Fig. 4-5 (A). Schematic plot of lnts~1/[ln(1+)]2 for CaOx homogeneous 
nucleation under the buffer effect of NaCl. Two fitted lines with different 
slopes intersect each other, dividing the space into two regimes.  
 
Fig. 4-5 (B). Plot of 
 
 f (m)   for CaOx nucleation with the effect of 
NaCl. With the increase of supersaturation, the interfacial correlation factor 
f m( )will increase abruptly at a certain supersaturation. 
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 4.2.3 The Effect of BSA on Nucleation Kinetics 
In order to examine the influence of the BSA on the nucleation kinetics, and the 
subsequent structure correlation effect on the CaOx crystallites, the ln(ts )  versus 
1 [ln(1+ )]2 plots were constructed for CaOx crystal when BSA was fixed at a series 
of concentrations, as presented in Fig. 4-6 (A). According to Eq. 2-13, for a given 
system (, B = constant), we can analyze the change of the structure correlation 
between the substrate and the crystalline phase in terms of the variation of the slope of 
these plots. As shown in Fig.4-6 (A), each of these depicted curves can be fitted by 
two intersecting straight lines with different slopes. This indicates that the nucleation 
is controlled by two discrete values of f m( )  within the corresponding supersaturation 
regions. As the supersaturation increases, f m( )  increases sharply. This implies that 
the structural match between the substrate and the nucleating crystallites deteriorates 
as the supersaturation increases. Moreover, with the presence of the BSA and the 
increase of BSA concentration, the ln(ts )  versus 1 [ln(1+ )]2 plots shift left, which 
indicates that the induction time increases, thus the CaOx nucleation process is 
prolonged. As the urinary stone formation is a time-restricted process, increasing the 




The supersaturation at which f m( )  changes is defined as *. A larger * implies that 
good crystalline alignment will be achieved in a wider range of supersaturations
65
. In 
Fig. 4-6 (A) and Fig. 4-6 (B), * for curve 1, curve 2 and curve 3 is 7.01102 , 
8.6 102 and 9.4 102 , respectively. The fact that 1* <  2* <  3*  shows that the * 
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Fig. 4-6 (B). Plot of 
 
 f (m)   for CaOx nucleation, with the influence of 
BSA at different concentration, Curve 1, no additive; Curve 2, with BSA at 
0.5mg/L; Curve 3, with BSA at 1mg/L. 
 
Fig. 4-6 (A). Plot of 
 
ln ts (sec)  1 [ln(1+ )]2  for calcium oxalate 
crystal nucleation under different conditions. Curve 1, no additive; 
Curve 2, with BSA at 0.5mg/L; Curve 3, with BSA at 1mg/L 
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exhibits a monotonic increase with BSA concentration. This implies that the presence 
of BSA plays a crucial role in suppressing the supersaturation-driven structure 
mismatch effect occurring in the crystalline assembly over a wider range of 
supersaturations. Since BSA can prolong the range of supersaturation for good 
structural match, we deduce from the above nucleation kinetics discussion, that a 
better CaOx crystallization assembly could be obtained in the presence of BSA.  
4.2.4 How Can the BSA Affect the CaOx Nucleation Process 
In the following, we will discuss how does BSA prolong the nucleation process of 
COM. First, let us review the general nucleation process: the growth units (molecules 
or ions) in the solution may, on collision, join into groups of two or more particles to 
form embryos. To reach a thermodynamically stable state, the embryos must 
overcome the nucleation energy barrier, thus attaining the “growth” of embryos
47, 70-
72
. During the “growth” of an embryo, growth units should be transported from the 
bulk solution to the surface of the embryo and become incorporated into the kink 
sites. However, when foreign bodies (impurities and/or protein molecules) are 
present, they become incorporated on the nucleus surface. This not only suppresses 
the nucleation barrier, but also affects the transport of growth units to the surface of 
the crystalline clusters
49, 65, 75
. The foreign body causes a reduction in the “effective 
surface” of the nucleus, which would normally be available for the growth units to 
incorporate themselves into the nucleus. This tends to slow down the nucleation 
kinetics
47, 65, 72, 75
, and increase the nucleation induction time.  
When solute molecules (growth units) are transported to the kink sites at the surface 
of an embryo [Fig. 4-7 (A), and Fig. 4-7 (B)], the probability for these molecules to 
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be incorporated to the embryo depends on various factors: the complexity of the 
molecules, the structure of solid-fluid interfaces, the adsorption of solvent or impurity 
molecules, and so forth. It has become a common practice to control nucleation by 
introducing additives. The effect of additives or impurities on the nucleation process, 
in terms of the structure of interfaces, is discussed here. 
To exert the effect of impurities or additives on nucleation, their molecules should 
adsorb onto the surface of embryo and/or the surface of substrate. Before growth units 
can be incorporated into the crystalline phase at the kink sites, the adsorbed impurities 
and solvent molecules should be removed (desorbed) first, as shown in Fig. 4-7 (A). 
Associated with this process, an energy barrier, so-called desolvation energy barrier 
Gkink+  needs to be overcome. The kinetics of kink integration can be described by the 
kink kinetics coefficient kink , which by definition is given by:  
                                                kink  vexp(G+ / kT ) ,                                         (4-4) 
 where v  is the frequency of vibration, and G+ denotes the free energy barrier of 
kink integration. It follows from recent theoretic analyses that G+  should include 
the desolvation energy barrier Gkink+ , the energy required to remove solvent or 
impurity molecules adsorbed at the kink sites, as shown in Fig. 4-7 (A).  
Obviously, the adsorption of additives on the surface of growing embryos will change 
 cf  to a small extent. However, as shown in Fig. 4-7 (B), to remove (desorbed) the 
additives (in this study, it is BSA) on the crystal surface or the kink sites, the 
desolvation energy barrier, (Gkink+  )add  should be overcome. As illustrated in Fig. 4-8,  
                                         (G+kink )add = (G+kink )add  Gkink+ .                          (4-5) 
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Fig. 4-7 (A). In the process of CaOx nucleation, water molecules enter 
kink sites on the embryo surface and kink site. They suppress the 
approach of growth units to the embryo. 
Fig. 4-7 (B). Illustration of adsorption of BSA molecules at the kink 
site and embryo surface. In the process of nucleation, the adsorption of 
additives at the kink sites suppresses the approach of growth units to 
the embryo.  
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In conclusion, the dominant effect of the additives is the enhancement of the 
desolvation energy barrier, which slows down the kink kinetics.  
Referring to others’ research conclusion
72, 74
, in the plot of ln ts  1 [ln(1+ )]2 , if y  
is the vertical shift of the straight lines, we have: 
y = (G+kink )add / kT ,                                            (4-6) 
where  = 16 cf32 / 3(kT )3 , as illustrated in Eq. 2-13. Therefore, in the plot of 
ln ts  1 [ln(1+ )]2 , once the vertical distance of these straight lines along the y  axis 
is calculated, the change in the desolvation energy can be identified. Consequently, 
the integration of growth units into crystal nuclei at the kink site will be significantly 




In our experiment, the presence of BSA inhibits crystal nucleation by absorbing at the 
kink sites. Thus, it increases the kink kinetics energy barrier and the induction time. 
Fig. 4-8. In the process of nucleation, the adsorption of additives at 
the kink site enhances the kink kinetics barrier by 
(G+kink )add = (G+kink )add  Gkink+  
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According to above discussion, in Fig. 4-6 (A), the vertical distance of the straight 
lines along the y  axis equals(G+kink )add / kT , from which we can calculate the 
change of the kink kinetics energy barrier (G+kink )add . We calculated this quantity 
for [Ca2+ ] = [C2O4
2 ] = 2.1mM , in the presence of BSA at the concentration of 
0.5mg/L and 1mg/L, and found that the energy barrier increase with reference to the 
case of homogeneous nucleation (where BSA is absent) is 0.62kT  and 1.07kT , 
respectively. When [Ca2+ ] = [C2O4
2 ] = 2.35mM , the energy barrier increase from 
homogeneous nucleation to nucleation in the presence of BSA of 0.5mg/L is 1.18kT . 
However, when [Ca2+ ] = [C2O4
2 ] = 2.45mM , the energy barrier increase with the 
increase in the BSA concentration from 0.5mg/L to 1mg/L is 1.18kT . 
  
CHAPTER FIVE  
CaOx Morphology Study 
From the previous chapter, we know that the BSA not only influences the CaOx 
nucleation kinetics, but also affects the crystal morphology. The experimental results 
of the previous chapter lead to the conclusion that the presence of BSA inhibits the 
CaOx crystallization and promotes a better crystal assembly in a wider range of 
supersaturation. However, as these conclusions are deduced only from the kinetics 
part, they should be treated with caution. Therefore, in this chapter, the CaOx crystal 
morphology is investigated to confirm the previous conclusions from kinetics study, 
and to elucidate the role the albumin plays in the CaOx crystallization. 
 
5.1 Sample Preparation 
To study the morphology change of the CaOx crystal, proper preparation of the 
samples is one of the most crucial steps. Only well-prepared samples can provide 
reproducible and reliable information, as any mistake would lead to unrepeatable 
results and wrong conclusion. In this section, the method to prepare the samples is 
introduced step by step in detail. 
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To examine the samples by SEM, cover glass was employed as the substrate to 
transfer the samples. At the beginning, the cover glass was cut into small square 
pieces of side length about 4mm , then was washed carefully using chromium acid, 
acetone and DI water several times to clean the contaminants adhered on the surface.  
Second: to obtain the crystals, the solutions of CaCl2 and NaOx were prepared 
separately by dissolving the reagents in deionized water to get the solution with the 
concentrations of 0.15mM , 0.2mM , 0.35mM , and 0.75mM . The solutions were 
sonicated for 20 minutes to increase the speed of dissolving
33
. Then these two kinds 
of solutions, of the same concentration, were mixed slowly. During the mixing 
process, the solution changed from clear to opaque, and small, white powder slowly 
precipitated at the bottom.  
Third: the small glasses prepared in the first step were dropped into the solution 
produced at the second step. These glasses settled at the bottom of the solution, and 
some crystals could adhere to the glass surface. Then, the sample solution was sealed 
by laboratory films and transferred to an oven, which was kept at a constant 
temperature of 37oC . 
Fourth: 20 hours later, the cover glass was removed from the solution and transferred 
into acetone using tweezers. In fact, when the samples were taken out of the solution, 
inevitably there would be some solution adhered to the glass surface. The solution 
would start evaporating once the cover glass was exposed to air. During the 
vaporization process, the concentration of the adhered solution would increase, and 
new crystal phase could form. This would cause an ambiguity that the crystal samples 
on the small glass were not those formed in the mixed solution, but those formed after 
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the glass had been taken out of the solution. To resolve this problem, the acetone was 
used to clean the solution adhered on the glass surface. As acetone can mix freely 
with water, the unwanted solution would dissolve into the acetone, and leave the glass 
surface. In this way, we guaranteed that the crystals examined corresponded to those 
formed at the required supersaturation. 
Fifth: the samples washed by acetone in the previous step were dried in the air. As the 
evaporation process of acetone is very fast, several minutes later, the acetone adhered 
on the glass disappeared leaving the glass dry. 
Sixth: the samples were then transferred to the SEM accessory, an auto fine coater. At 
the environment of nitrogen gas, with the pressure lower than 5Pa , a thin layer of 
platinum was coated on the sample surface. The purpose of this step is to increase the 
conductivity of the samples, thus making it observable by the SEM. 
In the last step, the samples were put on the sample stage of SEM and transferred to 
the sample chamber. Once the pressure of the chamber was lowered down to 
9.63105Pa , the observation started. 
In the study of examining the influence of ion strength on the crystal morphology, the 
sample preparation steps were the same as the mentioned above, except that sodium 
chloride (NaCl) was added to the mixture. In order to simulate the human body fluid, 
the sodium chloride concentration in the mixture was fixed at 140mM.  
As this study investigates the effect of the protein, BSA, on the crystal morphology, 
the above sample preparation procedure was repeated by adding the albumin to the 
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bulk solution at beginning. The concentration of protein was controlled in a large 
range from 10mg/L to 400mg/L, regardless of the supersaturation. 
The most important consideration in the method of preparation of the samples is that 
there are two consequences that could influence the crystallization process. The first 
is that, during the experiment, as the two bulk solutions are mixed together to produce 
crystal samples, inevitably turbulence is triggered, which increases the collision 
chance of ions. So the crystal nucleation and growth can be promoted. Moreover, the 
wall of the container and the inevitable existence of dust would play the role of 
substrate, whose templating effect would definitely lower the nucleation barrier, thus 
prompting the crystallization. Both of these consequences promote the crystallization 
process. This experimental method has these two unavoidable effects, so the results 
should be carefully discussed in order to avoid the possibility of reaching misleading 
conclusions. 
 
5.2 CaOx Morphology Study 
First, we found that the addition of sodium chloride to the solution did not produce 
much noticeable effect on the morphology change of the crystal. As we have 
discussed in the kinetics part, the addition of sodium chloride only enhances the ionic 
strength, and provides the buffer effect for nucleation. Moreover, based on the new 
nucleation theory, these changes only influence the nucleation barrier, not the crystal 
morphology. This conclusion has been confirmed by the crystal morphology study. 
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When the concentrations of Ca2+  and C2O4
2  were set to 0.15mM , no matter 
whether the BSA was present or not, the chance of detecting a crystal using SEM was 
very small. In most cases, we could not observe anything, except at very few times, 
we could catch a few small crystals, which were too small to be studied.  
This result can be explained by the following two reasons. According to Eq. 2-13 and 
Eq. 4-3, when [Ca2+ ] = [C2O4
2 ] = 0.15mM , the supersaturation is 7.3, which is only 
about 0.7 ~ 1.2%  of those investigated in the nucleation kinetics part. The 
supersaturation is so low that it is difficult to form enough large crystals to be 
observed by the SEM setup. However, as the experiment has been carried out by 
mixing the two bulk solutions, which inevitably caused turbulence resulting in an 
increase in the chance of ion collisions, the crystal nucleation and growth is promoted. 
What is more, the walls of the container and dust would play the role of substrate, 
whose templating effect definitely lowers the nucleation barrier, thus prompting 
crystallization. However, the correlated effect of the above-mentioned reasons leads 
to the result that only a few crystals have been observed. 
When the concentrations of Ca2+  and C2O4
2  are set to 0.2mM , the corresponding 
supersaturation is 13.2. Under this condition, excellent SEM images of the crystals 
were obtained, as shown in Fig. 5-1. This picture shows the SEM image of a twined 
COM obtained from the solution without the presence of BSA. However, once the 
BSA is added with the concentration higher than 20mg / L , we hardly observe any 
crystals, even though other conditions, such as supersaturation, pH and temperature, 
were kept unchanged. If the concentration of BSA is lower than 20mg/L, the effect of 
BSA is not very obvious on the crystal morphology. 
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This result is in accordance with the results obtained from the kinetics part and the 
related discussions. Based on the new nucleation theory and the kinetics results, we 
had arrived at the conclusion that the BSA can inhibit the nucleation of CaOx crystal. 
This conclusion was deduced merely from the fact that the presence of BSA increased 
the induction time, and increased the supersaturation range to obtain better crystal 
assembly. These conclusions are concretely confirmed by the SEM pictures. When 
the supersaturation equals 13.2, in the presence of BSA, we have observed hardly any 
crystals; however, twined crystals have been observed if the BSA is absent. (As 
shown in Fig. 5-1) 
According to the newly found nucleation theory, the BSA in the solution plays the 
role of template. On one hand, it lowers the nucleation barrier, thus promoting the 
Fig. 5-1. The SEM picture of COM twined crystal obtained from a solution 
at low concentration ( [Ca2+ ] = [C2O4
2 ] = 0.2mM ) without additives. 
Scale bar, 5μm 
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nucleation. On the other hand, the BSA can be incorporated into the embryo and/or 
crystal surface and kink sites. This effect reduces the effective nucleation surface and 
lowers the number of available kink sites for the incorporation of growth units. Thus 
the energy barrier to be overcome for crystal nucleation and/or growth
10, 13, 47, 69, 71, 73
 
increases. In this part of experiment, the combination of these two conflicting roles of 
BSA leads to the pictures we have shown.  
Fig. 5-2 is the SEM micrograph of randomly oriented COM crystals obtained from a 
solution, without the BSA, at high concentration ([Ca2+ ] = [C2O4
2 ] = 0.35mM ), the 
supersaturation being 38.06. This picture shows COM crystal with the disordered and 
highly aggregated morphology
39
. However, in the presence of BSA, keeping other 
conditions unchanged, an ordered COM assembly and the co-occurrence of COD and 
COM can be obtained, as shown in Fig. 5-3. For a clear view of the COD, a single 
COD crystal is also shown in Fig. 5-4.  
It is clear that the disordered crystal in Fig. 5-2 is caused by the supersaturation driven 
interfacial mismatch effect. During the kinetics study, we have deduced that the 
supersaturation driven interfacial mismatch effect could be alleviated by the BSA. 
This deduction has been confirmed by Fig. 5-3, which shows better ordered COM 
crystal than that in Fig. 5-2. This confirms that the synergy match effect can be 
achieved between the BSA and the COM, thus producing better crystal morphology 
and alleviating the interfacial mismatch effect. In the crystallization process of CaOx, 
the BSA performs templating effect, which is normally believed to improve the 
crystal morphology
20, 24, 31, 34, 65
. The templating effect has two consequences: first, it 
lowers the nucleation energy barrier, thus promoting the nucleation; second, the BSA 
can be incorporated to the kink sites and/or the embryo surface, which will slow down 
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Fig. 5-2. SEM micrograph showing COM crystallites obtained from a 
solution at high concentration ([Ca2+ ] = [C2O4
2 ] = 0.35mM ) without 
additives. Scale bar, 5μm 
Fig. 5-3. SEM micrograph showing COM and COD crystallites obtained 
from a solution at high concentration ([Ca2+ ] = [C2O4
2 ] = 0.35mM ) with 
BSA used as an additive. Due to the template effect of the biosubstrate, the 
crystallites show good structural synergy. Scale bar, 5μm 
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the nucleation process and/or crystal growth process. At the same time, the 
supersaturation always produces the supersaturation driven interfacial mismatch 
effect. This effect is more prevailing at higher supersaturations. Here, the two effects 
work against each other. Without the BSA, the supersaturation interfacial mismatch 
effect is the controlling factor, so in Fig. 5-2, the crystal has a disordered morphology. 
However, in the presence of BSA, the ordered COM morphology has been achieved 
by the templating effect, as seen in Fig. 5-3.  
In addition, the presence of BSA has also favored the formation of COD, as shown in 
Fig. 5-3 and Fig. 5-4. This is in agreement with the XRD experiments and discussion 
too. According to others’ research work
18, 102
, we know that the COD is less harmful 
to the kidney cell and urinary tubes than COM, and COD has a poor adherence ability 
than the COM. So the presence of BSA can be deemed as a reason that could trigger 
Fig. 5-4. SEM micrograph of a COD crystal, obtained from a 
solution at high concentration ([Ca2+ ] = [C2O4
2 ] = 0.35mM ) 
with BSA used as an additive. Scale bar 1μm 
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the formation of COD, the reason that the formation of urinary stone is inhibiated and 
the reason that explains why though the urine is saturated with the CaOx
37, 52, 79
, the 
urinary stone disease is not occurring to everyone.  
We saw that at the supersaturation of 38.06, the competition of the templating effect 
of BSA suppressed the supersaturation driven interfacial mismatch effect. However, 
once the concentration is set to [Ca2+ ] = [C2O4
2 ] = 0.75mM , the supersaturation is 
145.93, which is much higher than 38.06. Under such conditions, the supersaturation 
driven interfacial mismatch effect totally controls the crystallization process. As 
presented in Fig. 5-5, the SEM pictures show that at the supersaturation of 145.93 
with the BSA used as additive, both the COD and COM are disordered and distorted. 
It is clear that the high supersaturation
10, 13, 47, 65, 69, 71, 73
 results in the disordered 
crystal morphology. This mean that perfect crystal morphology is hard to get at very 
Fig. 5-5. SEM micrograph of co-existence of COM and COD 
crystals, obtained from a solution at high concentration 
([Ca2+ ] = [C2O4
2 ] = 0.75mM ) with BSA used as an additive. Scale 
bar 10μm 
 





The SEM experiments have confirmed the findings deduced from the nucleation 
kinetics study. Here, the SEM pictures provide direct proof that BSA can inhibit the 
nucleation of CaOx crystal, and can increase the supersaturation range for obtaining 
better crystal assembly. In this experiment, all the factors that affect the crystal 
nucleation, growth and aggregation are discussed. Such as the supersaturation driven 
interfacial mismatch effect, the templating effect of the protein, and the effect of 
adsorption on the kink sites and embryo surface. The driving force for nucleation is 
the supersaturation, which can produce the supersaturation driven interfacial 
mismatch effect; the substrate can lower the energy barrier for nucleation, however, it 
can also reduce the effective surface for the growth units to be incorporated to the 
embryo surface. The additives such as protein can be adsorbed on the kink site, thus 
increasing the kink site energy barrier. These factors compete with each other. 
Consequently, the BSA influences not only the nucleation process, but also the crystal 
morphology.  
The SEM pictures have also shown that the presence of BSA leads to the formation of 
COD. The medical benefit of the formation of COD rather than COM has been 
extensively discussed both in this part and in the previous chapter.  
  
CHAPTER SIX 
Discussion and Conclusion 
6.1 Results and Discussion 
In order to establish a better understanding of the crystallization of CaOx crystals 
under the effect of the protein BSA, based on a newly found nucleation theory, both 
the nucleation kinetics, and the structural synergy between the biomineral and the 
biosubstrate were examined in this study. 
Armed with the newly founded nucleation theory, the nucleation kinetics of CaOx 
crystals has been studied. From the experimental results, we find that the BSA favors 
the formation of COD crystals, which are absent in the absence of the BSA. In 
addition, the way the BSA influences the nucleation kinetics has also been discussed. 
First, the presence of BSA lowers the nucleation energy barrier, thus promoting the 
crystal nucleation. Second, during the nucleation process, the BSA adheres to the kink 
sites and/or the embryo surfaces, thus increasing the kink energy barrier, and slowing 
down the crystallization. In all, from the experimental data, we understand that the 
BSA prolongs the CaOx nucleation process. This is achieved by the nucleation 
induction time increase. From the nucleation kinetics study, we also deduce that the 
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protein can enlarge the supersaturation range to achieve a better crystal morphology. 
This conclusion has also been confirmed by the crystal morphology study using SEM.  
We also discussed the possible role of the albumin in treating the kidney stone. We 
know that COD is less likely to adhere to the urinary cells and tubes, and is less 
harmful to the kidney organ. In addition, the induction time increase makes the 
crystals to be more easily propelled out by urine. These three factors lead to the 
conclusion that the albumin plays a positive effect on preventing the urinary disease.   
The most exciting result of this study is that with the newly founded nucleation 
theory, the nucleation kinetics and the crystal morphology have been interconnected 
and discussed together. The method of this study can also been used to investigate 
how the other proteins, lipids and organic matrix influence the urinary stone disease.  
Moreover, it can also be further developed to study all the nucleation kinetics of the 
biological crystals. In future, this work can be extended to investigate more 
complicated phenomena in nature, and more useful findings can be obtained. 
However, though many achievements have been made in this study, some other 
questions have been raised, which await satisfactory answer. First, in this study, only 
the protein, albumin, is added and no other protein is considered. This raises the 
question about the possible role of other proteins and the possible combined effect of 
other proteins with albumin. Second, in real situation, there are many other ions in the 
kidney and urinary system. So, during the nucleation study, all of these ions should be 
considered. Third, in this study, we have not considered other organic matrix. The 
lack of other organic matter, for certainty, can make the study incomplete. Last, the 
nucleation, growth and assembly processes all happen in the urinary system, while, in 
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this study, structural information of kidney has not been considered. Though we have 
obtained much information about the substrate effect on CaOx crystallization, it is far 
from enough to understand the situation prevailing in the kidney, urinal tube and 
organs. Therefore, the nucleation theory must be advanced to make these points 
clearer. Moreover, though the sodium chloride is studied in the CaOx crystallization, 
its combinational effect with the albumin is still not clear.  In other words, though 
some progress has been made in studying the urinary stone and protein, this study has 
also put forward some questions, which need satisfactory answers. 
 
6.2 Recommendation for Further Research 
The study on the effect of albumin on CaOx crystal nucleation, with the aid of the 
newly found nucleation theory, has been carried out for the first time. The results are 
very encouraging. However, this project is only a preliminary study. Further research 
is recommended to clarify the following aspects.  
1. How do the other component in the urinary stone, such as the ions, proteins and 
lipids influence the CaOx crystal formation should be investigated. The combined 
role of other proteins, matrix and the kidney environment in the crystallization 
process makes the above question much complicated.  
2. The protein has complex structure, so how does it affect the nucleation and by what 
means need to be answered. Whether the protein is denatured and to what extent it has 
been denatured are still unknown. In addition, if the protein is in the denatured state, 
what is its effect on CaOx crystallization? 
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3. Other inorganic components of the urinary stones, such as hydroxyapatite and 
carbonate apatite, should also be introduced into the crystal and studied. 
4. Though in this study, the possible role of albumin in the formation of the urinary 
stone has been pointed out; it is still a long way to find a possible and reliable method 
to utilize this knowledge in medical treatment. 
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